SCHEMBL6629345

SCHEMBL6629345

Clc1c[c]cnc1Oc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 2/20 0.43
TSHR P16473 2/20 0.41
CYP2C9 P11712 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 2/20 0.41
APEX1 P27695 1/20 0.41
TRPA1 O75762 1/20 0.38
LTA4H P09960 2/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
ALDH1A1 P00352 3/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPC1 O15118 1/20 0.37
GAA P10253 1/20 0.37
RAB9A P51151 1/20 0.37
MAPK1 P28482 1/20 0.36
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2897638 0.86 CYP2C9 (0.49) TSHRCYP2C9SMN1; SMN2LMNAAPEX1
SCHEMBL2902878 0.80 LMNA (0.40) PIN1TSHRCYP2C9SMN1; SMN2LMNA
SCHEMBL2897637 0.79 LMNA (0.39) TSHRCYP2C9SMN1; SMN2LMNAAPEX1
SCHEMBL2903002 0.79 SMN1; SMN2 (0.42) TSHRCYP2C9SMN1; SMN2LMNAAPEX1
SCHEMBL2901895 0.77 HSPB1 (0.44) PIN1SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL15924716 0.72 MAPK8 (0.52) PIN1TSHRCYP2C9SMN1; SMN2LMNA
SCHEMBL27471024 0.71 LTA4H (0.46) PIN1TSHRCYP2C9SMN1; SMN2LTA4H
SCHEMBL20243481 0.69 LTA4H (0.48) TSHRCYP2C9SMN1; SMN2LMNALTA4H
SCHEMBL3060000 0.68 KDM4E (0.39) CYP2C9SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL4475588 0.68 L3MBTL1 (0.35) SMN1; SMN2L3MBTL1GAAHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444228-A2 SUBSTITUTED HETEROARYLALKANOIC ACIDS AND THEIR USE AS ALDOSE REDUCTASE INHIBITORS The Institutes for Pharmaceutical Discovery, LLC (US) 2004-08-11 EP disclosed
WO-2003044015-A2 SUBSTITUTED HETEROARYLALKANOIC ACIDS AND THEIR USE AS ALDOSE REDUCTASE INHIBITORS THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, LLC (US) 2003-05-30 WO disclosed